In HCC, TDO is highly expressed in tumour tissues and remarkably correlates with malignant phenotypic features such as tumour differentiation, tumour size and vascular invasion, with the possibility that it may be an efficient biomarker for the diagnosis and prognosis of HCC.169. Here, TDO2 is linked to hepatocellular carcinoma.